Published in Intern Emerg Med on May 22, 2010
Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain (2013) 0.83
An emerging problem in clinical practice: how to treat chronic headache patients. Intern Emerg Med (2010) 0.77
Dispute settlement understanding on the use of Botox in chronic migraine. J Headache Pain (2011) 0.76
Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China. BMC Neurol (2015) 0.75
'Ictal epileptic headache': recent concepts for new classifications criteria. Cephalalgia (2012) 3.19
Lifting the burden: the first 7 years. J Headache Pain (2010) 2.55
New policies to consolidate the journal's hold on its latest position. J Headache Pain (2009) 2.33
A tier-upon-tier march towards the impact factor. J Headache Pain (2008) 2.09
While climbing the hill, you think it's possible. J Headache Pain (2009) 1.97
Headache disorders are third cause of disability worldwide. J Headache Pain (2015) 1.93
The Journal of Headache and Pain keeps gaining consensus. J Headache Pain (2010) 1.70
Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain (2009) 1.60
The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action. J Headache Pain (2011) 1.52
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important. Intern Emerg Med (2015) 1.52
Time to act on headache disorders. J Headache Pain (2011) 1.47
The definitive position of headache among the major public health challenges. An end to the slippery slope of disregard. J Headache Pain (2007) 1.40
Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39
Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain (2011) 1.39
Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain (2006) 1.38
Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat (2010) 1.37
Headache and emergency medicine: sharing a language for a common project. Intern Emerg Med (2008) 1.36
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.31
Psychometric properties of the stagnation scale in medication overuse headache patients. J Headache Pain (2015) 1.29
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain (2011) 1.22
Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready. J Headache Pain (2013) 1.19
Chronicling the June conundrum. J Headache Pain (2011) 1.18
The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders. J Headache Pain (2013) 1.17
Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs (2012) 1.10
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain (2013) 1.09
Framing comorbidities and co-occurrences in a migraine with aura patient. Intern Emerg Med (2014) 1.07
Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia. J Headache Pain (2008) 1.05
Headache medicine: academic teaching in Europe. The Sapienza University Master's Degree. Headache (2007) 1.05
Tumor necrosis factor gene polymorphism in migraine. Headache (2002) 1.04
A tasty cultural event. J Headache Pain (2012) 1.04
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? J Headache Pain (2013) 1.02
Academic specialist education in headache medicine. Next move for the headache community. J Headache Pain (2005) 1.02
Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med (2010) 1.02
Ictal epileptic headache: an old story with courses and appeals. J Headache Pain (2012) 1.02
Refractory headache: one term does not cover all--a statement of the European Headache Federation. J Headache Pain (2014) 0.95
Overattachment and perceived disability in chronic migraineurs. Clin Neurol Neurosurg (2012) 0.94
Improving care through health economics analyses: cost of illness and headache. J Headache Pain (2008) 0.93
Future drugs for migraine. Intern Emerg Med (2009) 0.93
Pharmacokinetic evaluation of almotriptan for the treatment of migraines. Expert Opin Drug Metab Toxicol (2013) 0.92
Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain (2010) 0.89
Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache. J Headache Pain (2008) 0.89
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas (2010) 0.88
White matter hyperintensities and self-reported depression in a sample of patients with chronic headache. J Headache Pain (2012) 0.88
The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers. J Headache Pain (2008) 0.87
Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations. J Headache Pain (2013) 0.87
Treatment of perimenstrual migraine with triptans: an update. Curr Pain Headache Rep (2012) 0.86
Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain (2010) 0.86
Pharmacokinetic evaluation of frovatriptan. Expert Opin Drug Metab Toxicol (2011) 0.86
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study. J Headache Pain (2012) 0.84
Update on Medication-Overuse Headache and Its Treatment. Curr Treat Options Neurol (2015) 0.84
Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice. Expert Opin Pharmacother (2012) 0.84
Genetics of migraine and pharmacogenomics: some considerations. J Headache Pain (2007) 0.83
Sodium channel antagonists for the treatment of migraine. Expert Opin Pharmacother (2014) 0.83
Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraine. J Headache Pain (2006) 0.82
Treatment of menstrual migraine: utility of control of related mood disturbances. Expert Rev Neurother (2014) 0.82
Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy. Expert Opin Drug Metab Toxicol (2010) 0.82
Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines. Expert Opin Drug Metab Toxicol (2012) 0.82
Pharmacogenomics in migraine: catching biomarkers for a predictable disease control [corrected]. Expert Rev Neurother (2009) 0.81
Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity. Expert Opin Pharmacother (2013) 0.81
CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin Investig Drugs (2012) 0.81
Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches. Expert Opin Drug Metab Toxicol (2014) 0.80
Headache and mood disorders. J Headache Pain (2005) 0.80
Deciphering the task of N-acetyl aspartate in migraine. Expert Rev Neurother (2012) 0.79
Pharmacogenetic insights into migraine treatment in children. Pharmacogenomics (2014) 0.78
Emerging drugs for migraine treatment. Expert Opin Emerg Drugs (2014) 0.78
Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A>G) and migraine. J Headache Pain (2005) 0.77
Migraine with aura, bipolar depression, ACM aneurysm. A case report. J Headache Pain (2005) 0.77
Aspirin and tension-type headache. J Headache Pain (2007) 0.76
Dispute settlement understanding on the use of Botox in chronic migraine. J Headache Pain (2011) 0.76
The therapeutic potential of novel anti-migraine acute therapies. Expert Opin Investig Drugs (2014) 0.76
The omics in migraine. J Headache Pain (2013) 0.76
Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic class. Expert Rev Neurother (2008) 0.76
Efficacy and tolerability of almotriptan in menstrual migraine: a comment. Expert Opin Pharmacother (2011) 0.76
Neuroendocrine derangement in chronic migraine. Headache (2006) 0.75
Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population. Expert Rev Neurother (2015) 0.75